Free Trial
NASDAQ:BIOX

Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Bioceres Crop Solutions logo
$4.17 -0.42 (-9.15%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$4.18 +0.00 (+0.12%)
As of 05/5/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bioceres Crop Solutions Stock (NASDAQ:BIOX)

Key Stats

Today's Range
$4.17
$4.59
50-Day Range
$3.70
$5.22
52-Week Range
$3.51
$13.18
Volume
198,301 shs
Average Volume
169,389 shs
Market Capitalization
$261.50 million
P/E Ratio
208.60
Dividend Yield
N/A
Price Target
$8.63
Consensus Rating
Buy

Company Overview

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Bioceres Crop Solutions Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

BIOX MarketRank™: 

Bioceres Crop Solutions scored higher than 57% of companies evaluated by MarketBeat, and ranked 96th out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Bioceres Crop Solutions has only been the subject of 3 research reports in the past 90 days.

  • Read more about Bioceres Crop Solutions' stock forecast and price target.
  • Earnings Growth

    Earnings for Bioceres Crop Solutions are expected to grow in the coming year, from ($0.05) to $0.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bioceres Crop Solutions is 208.60, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.95.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bioceres Crop Solutions is 208.60, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 15.45.

  • Price to Book Value per Share Ratio

    Bioceres Crop Solutions has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bioceres Crop Solutions' valuation and earnings.
  • Percentage of Shares Shorted

    3.83% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently decreased by 9.03%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bioceres Crop Solutions does not currently pay a dividend.

  • Dividend Growth

    Bioceres Crop Solutions does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.83% of the float of Bioceres Crop Solutions has been sold short.
  • Short Interest Ratio / Days to Cover

    Bioceres Crop Solutions has a short interest ratio ("days to cover") of 4.7.
  • Change versus previous month

    Short interest in Bioceres Crop Solutions has recently decreased by 9.03%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Bioceres Crop Solutions has a news sentiment score of 1.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bioceres Crop Solutions this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.

  • Percentage Held by Institutions

    Only 17.68% of the stock of Bioceres Crop Solutions is held by institutions.

  • Read more about Bioceres Crop Solutions' insider trading history.
Receive BIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioceres Crop Solutions and its competitors with MarketBeat's FREE daily newsletter.

BIOX Stock News Headlines

Bioceres price target lowered to $7 from $8 at Oppenheimer
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

BIOX Stock Analysis - Frequently Asked Questions

Bioceres Crop Solutions' stock was trading at $6.08 on January 1st, 2025. Since then, BIOX stock has decreased by 31.4% and is now trading at $4.17.
View the best growth stocks for 2025 here
.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) posted its quarterly earnings data on Monday, November, 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.11. The business earned $92.60 million during the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a net margin of 0.58% and a trailing twelve-month return on equity of 0.68%.
Read the conference call transcript
.

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering (IPO) on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey served as the underwriters for the IPO and Mirabaud Securities was co-manager.

Top institutional investors of Bioceres Crop Solutions include Allianz Asset Management GmbH (0.38%), Ping Capital Management Inc. (0.09%) and Avanza Fonder AB (0.03%).

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Builders FirstSource (BLDR) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
11/11/2024
Today
5/05/2025
Next Earnings (Estimated)
6/04/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural chemicals
Sub-Industry
Trading
Current Symbol
NASDAQ:BIOX
Fax
N/A
Employees
500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.63
High Stock Price Target
$13.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+102.5%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
213.61
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.24 million
Pretax Margin
-1.07%

Debt

Sales & Book Value

Annual Sales
$407.73 million
Cash Flow
$0.37 per share
Price / Cash Flow
11.67
Book Value
$5.56 per share
Price / Book
0.77

Miscellaneous

Free Float
N/A
Market Cap
$267.15 million
Optionable
Optionable
Beta
0.40
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:BIOX) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners